JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

CRACD Antibodies

AND CRACD ELISA kits, CRACD Proteins

Many biological assays use antibodies to detect CRACD, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with CRACD in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop CRACD antibodies...

We validate the specificity of these antibodies to CRACD by testing them on tissues known to express CRACD positively and negatively. Browse below to find the CRACD antibody that suites your experiment. We have 0 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: Septin9 Next: NLN

CRACD Infographic by Boster Bio

CRACD protein infographic

All CRACD Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

CRACD Overview

Facts about Capping protein inhibiting regulator of actin dynamics.

CRACD 3D structure

CRACD 3D structure. Source: alphafold

Capping protein inhibiting regulator of actin dynamics (CRACD)

Gene Information

Human
Gene Name:	CRACD
Uniprot:	Q6ZU35
Entrez:	57482

Gene Information

Family

Belongs to:

No superfamily

Family

Alternative Names

Capping protein inhibiting regulator of actin dynamics

Molecular Weight

Mass (kDA):
136.76 kDA

Molecular Weight

Genomic Context


Human

Location:	4q12
Sequence:	4; NC_000004.12 (56049222..56330724)

Subcellular Localizations

Cytoplasm, cytosol.

Subcellular Localization

PTMs

Phosphoprotein

Bosterbio | ELISA Kits, Antibodies, Antibody Company

For details, visit:
bosterbio.com/bosterbio-gene-info-cards/CRACD

References

PMID: 27717682 by Mukawa M., et al. Exome sequencing identified CCER2 as a novel candidate gene for Moyamoya disease.

PMID: 30361697 by Jung Y.S., et al. Deregulation of CRAD-controlled cytoskeleton initiates mucinous colorectal cancer via beta-catenin.